Royalty Pharma plc - CLASS A COMMON STOCK (RPRX)

CUSIP: G7709Q104

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+2,593,500
Put/Call ratio
13%
SEC-reported price per share
$36.03
Number of holders
331
Value change
+$87,185,612
Number of buys
186
Open additional details 1 more signal available
Number of sells
139
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
448,578,615

Security key

G7709Q104

Report period

Q1 2023

Institutions

331

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GG 1978 SICAF SIF S.A.
Disclosed value leader
MORGAN STANLEY
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $1,946,203,263 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY has the largest disclosed position value at $1.95B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Disclosed position value Top 5
GG 1978 SICAF SIF S.A. $608.28M
GG 1978 SICAF SIF S.A. - GG Strat... $590.24M
MORGAN STANLEY $1.95B
VANGUARD GROUP INC $1.41B
BlackRock Finance, Inc. $767.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GG 1978 SICAF SIF S.A.
3/4/5
10%+ Owner
—
denominator unverified
$608,282,853
22,081,156 shares
— 14 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic
3/4/5
10%+ Owner
—
denominator unverified
$590,239,561
21,426,170 shares
— 20 Sep 2022
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$1,946,203,263
49,246,032 shares
— 31 Dec 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,408,010,301
35,627,791 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$767,211,684
19,413,251 shares
— 31 Dec 2022
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$676,554,025
17,119,282 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
331
Shares
301,740,017
Rows available
331
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
331
Q1 2023 holders
331
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .